| BUFBX | VVIAX | BUFBX / VVIAX | |
| Total Expense Ratio | 1.01 | 0.05 | 2,020% |
| Annual Report Gross Expense Ratio | 1.01 | 0.05 | 2,020% |
| Fund Existence | 31 years | 25 years | - |
| Gain YTD | 10.234 | 12.640 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 452M | 208B | 0% |
| Annual Yield % from dividends | 1.55 | 2.04 | 76% |
| Returns for 1 year | 2.58 | 6.10 | 42% |
| Returns for 3 years | 18.77 | 30.82 | 61% |
| Returns for 5 years | 54.79 | 60.40 | 91% |
| Returns for 10 years | 84.33 | 128.90 | 65% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TEKY | 38.20 | 0.67 | +1.77% |
| Lazard Next Gen Technologies ETF | |||
| EVUS | 31.99 | 0.28 | +0.88% |
| iShares ESG Aware MSCI USA Value ETF | |||
| FEBU | 27.78 | 0.12 | +0.43% |
| AllianzIM U.S. Equity Buffer15 UncFebETF | |||
| FLGV | 20.66 | 0.03 | +0.15% |
| Franklin U.S. Treasury Bond ETF | |||
| FTHF | 31.89 | 0.01 | +0.03% |
| FT EM Human Flourishing ETF | |||